MicuRx Pharmaceutical Advances Contezolid Trial for Diabetic Foot Infections with Positive Outcomes MicuRx Pharmaceutical has made notable advancements in its Phase III clinical trial for treating diabetic foot infections, buoyed by positive evaluations.

MicuRx Pharmaceutical Advances Contezolid Trial for Diabetic Foot Infections with Positive Outcomes #China #Shanghai #MicuRx #MRX-4 #Contezolid

Shanghai MicuRx Pharmaceutical Concludes Successful Phase III MRX-4 Trial for Soft Tissue Infections Shanghai MicuRx Pharmaceuticals has successfully completed the Phase III clinical trial for MRX-4, an innovative treatment for complex skin infections, paving the way for its commercialization in China.

Shanghai MicuRx Pharmaceutical Concludes Successful Phase III MRX-4 Trial for Soft Tissue Infections #China #Shanghai #MicuRx #MRX-4 #Contezolid